Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension

Pathology Research and Practice

Volumn 203, Issue 12, 2007, Pages 863-872

  Umar, Soban ^a   Hessel, Marleen ^a   Steendijk, Paul ^a   Bax, Wilhelmina ^a   Schutte, Cindy ^a   Schalij, Martin ^a   van der Wall, Ernst ^a   Atsma, Douwe ^a   van der Laarse, Arnoud ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Focal adhesion kinase; Heart failure; Hypertrophy; Matrix metalloproteinase; Neuronal nitric oxide synthase

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; INTEGRIN; MATRIX METALLOPROTEINASE; MONOCROTALINE; NEURONAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME PHOSPHORYLATION; HEART MUSCLE; HEART MUSCLE CELL; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WEIGHT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NEWBORN; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION;

EID: 35748958061     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.08.006     Document Type: Article

References (39)

1. Altieri P., Brunelli C., Garibaldi S., Nicolino A., Ubaldi S., Spallarossa P., Olivotti L., Rossettin P., Barsotti A., and Ghigliotti G. Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. Eur. J. Clin. Invest. 33 (2003) 648-656
2. Banfi C., Cavalca V., Veglia F., Brioschi M., Barcella S., Mussoni L., Boccotti L., Tremoli E., Biglioli P., and Agostoni P. Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure. Eur. Heart J. 26 (2005) 481-488
3. Barouch L.A., Harrison R.W., Skaf M.W., Rosas G.O., Cappola T.P., Kobeissi Z.A., Hobai I.A., Lemmon C.A., Burnett A.L., O'Rourke B., Rodriguez E.R., Huang P.L., Lima J.A.C., Berkowitz D.E., and Hare J.M. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416 (2002) 337-340
4. Bayer A.L., Heidkamp M.C., Patel N., Porter M.J., Engman S.J., and Samarel A.M. PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H695-H706
5. Bendall J.K., Damy T., Ratajczak P., Loyer X., Monceau V., Marty I., Milliez P., Robidel E., Marotte F., Samuel J.L., and Heymes C. Role of myocardial neuronal nitric oxide synthase derived nitric oxide in β-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation 110 (2004) 2368-2375
6. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7 (1995) 728-735
7. Buermans H.P., Redout E.M., Schiel A.E., Musters R.J., Zuidwijk M., Eijk P.P., van Hardeveld C., Kasanmoentalib S., Visser F.C., Ylstra S., and Simonides W.S. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated hypertrophy or heart failure. Physiol. Genomics 21 (2005) 314-323
8. Cowan K.N., Heilbut A., Humpl T., Lam C., Ito S., and Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat. Med. 6 (2000) 698-702
9. Damy T., Ratajczak P., Robidel E., Bendall J.K., Olivero P., Boczkowski J., Ebrahimian T., Marotte F., Samuel J.L., and Heymes C. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J. 17 (2003) 1934-1936
10. Damy T., Ratajczak P., Shah A.M., Camors E., Marty I., Hasenfuss G., Marotte F., Samuel J.L., and Heymes C. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363 (2004) 1365-1367
11. Dawson D., Lygate C.A., Zhang M.H., Hulbert K., Neubauer S., and Casadei B. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112 (2005) 3729-3737
12. Deschamps A.M., and Spinale F.G. Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation. Cardiovasc. Res. 59 (2006) 666-676
13. Ghodsi F., and Will J.A. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am. J. Physiol. 240 (1981) H149-H155
14. Hessel M.H.M., Steendijk P., den Adel B., Schutte C.I., and van der Laarse A. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H2424-H2430
15. Hislop A., and Reid L. Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats. Br. J. Exp. Pathol. 55 (1974) 153-163
16. Ito K.M., Sato M., Ushijima K., Nakai M., and Ito K. Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H1786-H1795
17. Laser M., Willey C.D., Jiang W., Cooper IV G., Menick D.R., Zile M.R., and Kuppuswamy D. Integrin activation and focal complex formation in cardiac hypertrophy. J. Biol. Chem. 275 (2000) 35624-35630
18. MacKenna D.A., Dolfi F., Vuori K., and Ruoslahti E. Extracellular signal regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. J. Clin. Invest. 101 (1998) 301-310
19. Martinez-Ruiz A., and Lamas S. S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc. Res. 62 (2004) 43-52
20. Migita K., Maeda Y., Abiru S., Komori A., Yokoyama T., Takii Y., Nakamura M., Yatsuhashi H., Eguchi K., and Ishibashi H. Peroxynitrite-mediated matrix metalloproteinase-2 activation in human hepatic stellate cells. FEBS Lett. 579 (2005) 3119-3125
21. Morita H., Khanal S., Rastogi S., Suzuki G., Imai M., Todor A., Sharov V.G., Goldstein S., O'Neill T.P., and Sabbah H.N. Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2522-H2527
22. Rosenberg H.C., and Rabinovitch M. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am. J. Physiol. 255 (1988) H1484-H1491
23. Ross R.S., and Borg T.K. Integrins and the myocardium. Circ. Res. 88 (2001) 1112-1119
24. Ruwhof C., van Wamel A.E.T., Egas J.M., and van der Laarse A. Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts. Mol. Cell. Biochem. 208 (2000) 89-98
25. Shyy J.Y.J., and Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr. Opin. Cell Biol. 9 (1997) 707-713
26. Sjaastad M.D., Lewis R.S., and Nelson W.J. Mechanisms of integrin-mediated calcium signaling in MDCK cells: regulation of adhesion by IP3- and stress-independent calcium influx. Mol. Biol. Cell. 7 (1996) 1025-1041
27. Spinale F.G. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ. Res. 90 (2002) 520-530
28. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., and Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure. Circ. Res. 82 (1998) 482-495
29. Stoyanovski D., Murphy T., Anno P.R., Kim Y.M., and Salama G. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell. Calcium 21 (1997) 19-29
30. Sumeray M.S., Rees D.D., and Yellon D.M. Infarct size and nitric oxide synthase in murine myocardium. J. Mol. Cell. Cardiol. 32 (2000) 35-42
31. Tyagi S.C., Kumar S.G., Haas S.J., Reddy H.K., Voelker D.J., Hayden M.R., Demmy T.L., Schmaltz R.A., and Curtis J.J. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy. J. Mol. Cell. Cardiol. 28 (1996) 1415-1428
32. A. van der Laarse, C.C. van der Wees, E.J. van der Valk, W.H. Bax, Integrin stimulation induced signaling includes phosphorylation of focal adhesion kinase and nitric oxide synthase-1 leading to elevation of intracellular NO and calcium concentrations in cardiomyocytes, Circulation 112 (Abstract 2005) II-1114.
33. van der Wees C.G.C., Bax W.H., van der Valk E.J.M., and van der Laarse A. Integrin stimulation induces calcium signalling in rat cardiomyocytes by a NO-dependent mechanism. Pflügers Arch. - Eur. J. Physiol. 451 (2006) 588-595
34. Vila Petroff M.G., Kim S.H., Pepe S., Dessy C., Marban E., Balligand J.L., and Sollott S.J. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat. Cell Biol. 3 (2001) 867-873
35. Wang W., Sawicki G., and Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc. Res. 53 (2002) 165-174
36. Werchan P.M., Summer W.R., Gerdes A.M., and McDonough K.H. Right ventrcular performance after monocrotaline-induced pulmonary hypertension. Am. J. Physiol. 256 (1989) H1328-H1336
37. Wilson D.W., Segall H.J., Pan L.C., Lame M.W., Estep J.E., and Morin D. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit. Rev. Toxicol. 22 (1992) 307-325
38. Xu L., Eu J.P., Meissner G., and Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279 (1998) 234-237
39. Yan A.T., Yan R.T., Spinale F.G., Afzal R., Gunasinghe H.R., Arnold M., Demers C., Mckelvie R.S., and Liu P.P. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure. J. Card. Fail. 12 (2006) 514-519